Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IRAK4 | Q9NWZ3 | 2/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | ACHE | P22303 | 1/20 | 0.50 |
| ▸ | IDO1 | P14902 | 1/20 | 0.49 |
| ▸ | TDO2 | P48775 | 1/20 | 0.49 |
| ▸ | KCNK3 | O14649 | 2/20 | 0.47 |
| ▸ | KCNK9 | Q9NPC2 | 2/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.42 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.42 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.42 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.42 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.42 |
| ▸ | MRGPRX1 | Q96LB2 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | CTSD | P07339 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7088362 | 0.84 | IRAK4 (0.72) | IRAK4ALDH1A1ACHEIDO1TDO2 | |
| SCHEMBL2094692 | 0.84 | IRAK4 (0.72) | IRAK4ALDH1A1ACHEIDO1TDO2 | |
| SCHEMBL28293902 | 0.82 | IRAK4 (0.70) | IRAK4ALDH1A1ACHEIDO1TDO2 | |
| SCHEMBL104892 | 0.82 | IRAK4 (0.70) | IRAK4ALDH1A1ACHEIDO1TDO2 | |
| SCHEMBL19924675 | 0.82 | IRAK4 (0.47) | IRAK4ALDH1A1IDO1TDO2ALOX15 | |
| SCHEMBL2103513 | 0.81 | IRAK4 (1.00) | IRAK4ALDH1A1ACHEIDO1TDO2 | |
| SCHEMBL16674268 | 0.81 | IRAK4 (0.68) | IRAK4ALDH1A1ACHEIDO1TDO2 | |
| SCHEMBL2094687 | 0.81 | IRAK4 (0.68) | IRAK4ALDH1A1ACHEIDO1TDO2 | |
| Bicarbonate SCHEMBL21811920 | 0.81 | IRAK4 (0.68) | IRAK4ALDH1A1ACHEIDO1TDO2 | |
| SCHEMBL10763308 | 0.81 | IRAK4 (0.68) | IRAK4ALDH1A1ACHEIDO1TDO2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120082181-A | PBAT/bamboo powder biodegradable composite master batch, preparation method thereof and composite film | 国际竹藤中心 | 2025-06-03 | — | — | CN | claimed |
| CN-120082181-A | PBAT/bamboo powder biodegradable composite master batch, preparation method thereof and composite film | 国际竹藤中心 | 2025-06-03 | — | — | CN | disclosed |
| EP-2844345-B1 | MODULATORS OF THE RELAXIN RECEPTOR 1 | US HEALTH (US) | 2022-08-03 | — | — | EP | disclosed |
| EP-3507271-B1 | VERFAHREN ZUR HERSTELLUNG VON SALICYLOYL-L-CARNITIN-HYDROCHLORID | DRUGON PHARMA SWITZERLAND AG (CH) | 2021-09-29 | — | — | EP | disclosed |
| US-10723691-B2 | Process for preparing salicyloyl-L-carnitine hydrochloride | DRUG'ON PHARMA SWITZERLAND AG (CH) | 2020-07-28 | — | — | US | disclosed |
| EP-3326999-B1 | SALICYLOYLCARNITIN SULFONATES | DRUGON PHARMA SWITZERLAND AG (CH) | 2019-08-07 | — | — | EP | disclosed |
| EP-3507271-A1 | PROCESS FOR PREPARING SALICYLOYL-L-CARNITINE HYDROCHLORIDE | Drug'On Pharma Switzerland AG (CH) | 2019-07-10 | — | — | EP | disclosed |
| US-20190202775-A1 | PROCESS FOR PREPARING SALICYLOYL-L-CARNITINE HYDROCHLORIDE | DRUG'ON PHARMA SWITZERLAND AG (CH) | 2019-07-04 | — | — | US | disclosed |
| EP-3184171-B1 | PHOSPHINYL AMIDINE COMPOUNDS, METAL COMPLEXES, CATALYST SYSTEMS, AND THEIR USE TO OLIGOMERIZE OR POLYMERIZE OLEFINS | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2019-03-20 | — | — | EP | disclosed |
| US-10144752-B2 | Phosphinyl amidine compounds, metal complexes, catalyst systems, and their use to oligomerize or polymerize olefins | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2018-12-04 | — | — | US | disclosed |
| US-7332629-B2 | Modulators (inhibitors/activators) of histone acetyltransferases | JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH (IN) | 2008-02-19 | — | — | US | disclosed |
| US-20060167107-A1 | Modulators (inhibitors/ activators) of histone acetyltransferases | JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH (IN) | 2006-07-27 | — | — | US | disclosed |
| EP-1590318-A2 | MODULATORS (INHIBITORS/ACTIVATORS) OF HISTONE ACETYLTRANSFERASES | Jawaharlal Nehru Centre For Advanced Scientific Research (IN) | 2005-11-02 | — | — | EP | disclosed |
| WO-2004053140-A2 | MODULATORS (INHIBITORS/ACTIVATORS) OF HISTONE ACETYLTRANSFERASES | JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH (IN) | 2004-06-24 | — | — | WO | disclosed |
| EP-0598756-B1 | ESTER COMPOSITION | SHELL INT RESEARCH (NL) | 1996-06-05 | — | — | EP | disclosed |
| EP-0636626-A1 | Pyrazolopyrimidine Derivatives | LABORATOIRES GLAXO SA (FR) | 1995-02-01 | — | — | EP | disclosed |
| US-5332858-A | Esterification with active phenolic ether and chloroformyl group and active phenol | SHELL OIL COMPANY (US) | 1994-07-26 | — | — | US | disclosed |
| EP-0598756-A1 | ESTER COMPOSITION. | SHELL INT RESEARCH (NL) | 1994-06-01 | — | — | EP | disclosed |
| WO-1993002038-A1 | ESTER COMPOSITION | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 1993-02-04 | — | — | WO | disclosed |
| US-4251531-A | ANTIALLERGENS | FARMITALIA CARLO ERBA S.P.A. (IT) | 1981-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190202775-A1 | PROCESS FOR PREPARING SALICYLOYL-L-CARNITINE HYDROCHLORIDE | CRAT, CPT1B, MCCC2 | IRAK4 954/4885ALDH1A1 859/4885ACHE 2077/4885 |
| US-20060167107-A1 | Modulators (inhibitors/ activators) of histone acetyltransferases | EP300, HDAC1, KAT2A | IRAK4 2407/4885ALDH1A1 962/4885ACHE 517/4885 |
| US-10144752-B2 | Phosphinyl amidine compounds, metal complexes, catalyst systems, and their use to oligomerize or polymerize olefins | NIT2, NCLN, NPM1 | IRAK4 4402/4885ALDH1A1 4849/4885ACHE 1107/4885 |
| US-10723691-B2 | Process for preparing salicyloyl-L-carnitine hydrochloride | CRAT, CPT1B, MCCC2 | IRAK4 954/4885ALDH1A1 859/4885ACHE 2077/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.